Dr Deme Karikios is a medical oncologist and head of department at Nepean Hospital in Sydney. He has a clinical and research interest in thoracic and gastrointestinal malignancies. Deme also has a research interest in costs and value of anticancer drugs, decisions about treatment with expensive unsubsidised anticancer drugs and financial toxicity. He was awarded his PhD in 2019, entitled “The consequences of rising anticancer drug costs in Australia” which he undertook at the NHMRC Clinical Trials Centre, University of Sydney. Deme is a founding member of the Common Sense Oncology movement and active member of the COSA Financial Toxicity Working Group. Deme has co-supervised several PhD students and is a senior clinical lecturer at the University of Sydney. Deme has an interest in cancer care policy and is a past chair of the Medical Oncology Group of Australia.